Northwestern Mutual Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
USCWA
SWP
AA
CFD
Northwestern Mutual Wealth Management's GNOM Position: Q1 2026 in Review
Northwestern Mutual Wealth Management held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q1 2026 at 137 shares worth $5.99K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.
Northwestern Mutual Wealth Management first reported a position in GNOM in Q2 2022 and has held it in 16 quarters since. The position peaked at $92M in Q1 2023. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.
- Northwestern Mutual Wealth Management held 137 shares of Global X Genomics & Biotechnology ETF worth $5.99K as of Q1 2026.
- Northwestern Mutual Wealth Management left its Global X Genomics & Biotechnology ETF share count unchanged in Q1 2026.
- Global X Genomics & Biotechnology ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3243 holding.
- Northwestern Mutual Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q2 2022 and has held it in 16 quarters since.
- Northwestern Mutual Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $92M in Q1 2023.
- 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.